News

Cochrane rapid review investigates the use of convalescent plasma to treat people with COVID-19
Cochrane rapid review investigates the use of convalescent plasma to treat people with COVID-19
People who have recovered from COVID-19 develop natural defences to the disease in their blood (antibodies). Antibodies are found in part of the blood called plasma. Plasma from blood donated from recovered patients, which contains COVID-19 antibodies, can be used to make two preparations. Firstly, convalescent plasma, which is plasma that contains these antibodies. Secondly, hyperimmune immunoglobulin, which is more concentrated, and therefore contains more antibodies.
Coronavirus (COVID-19): infection control and prevention measures
This Special Collection is one of two collections on COVID-19, and it focuses on infection control and prevention measures. See also the companion Special Collection: Coronavirus (COVID-19): evidence relevant to critical care.The 2019 Coronavirus outbreak (COVID-19) was declared a global Public Health Emergency by the World Health Organization (WHO) on 30th January 2020.
Coronavirus (COVID-19): evidence relevant to critical care
This Special Collection is one of two collections on COVID-19, and it focuses on evidence relevant to critical care. See also the companion Special Collection: Coronavirus (COVID-19): infection control and prevention measures.
Cochrane International Mobility
Getting involved in Cochrane’s work means becoming part of a global community. Connect with Cochrane Groups across the world through the Cochrane International Mobility programme!
Networks of Cochrane Review Groups
Maternity Matters: A new special series of blogs and other resources from Cochrane UK
Throughout August, the Cochrane UK team are running a new special series; ‘Maternity Matters’.
Cochrane Iran and Cochrane Canada held a meeting in Tehran, Iran
Tehran, 9 July 2019- There was an opportunity for Cochrane Iran to present their main activities, plans and successes in recent years in an amicable meeting with Dr. Holger Jens Schünemann, Director of Cochrane Canada during his trip to Tehran. This was arranged by World Health Organization Office in Tehran as his consultancy in order to review guideline development process in the Ministry of Health and Medical Education.
Cochrane's 30 under 30: Ahmad Sofi Mahmudi
Cochrane is made up of 11,000 members and over 67,000 supporters come from more than 130 
Cochrane Iran and the I.R. Iran Medical Council signed a Memorandum of Understanding
Cochrane Iran and the Islamic Republic of Iran Medical Council (IRIMC) recently signed a Memorandum of Understanding (MoU) to introduce achievements of both parties, implement joint training activities, and enhance the evidence- based practice in Iran.
Join the Rapid, Rapid, Rapid study and help answer an important methodological question!
The Cochrane Rapid Review Methods Group